Phibro Animal Health/$PAHC
1D1W1MYTD1Y5YMAX
About Phibro Animal Health
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
- Ticker
- $PAHC
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 2,475
- Headquarters
- Teaneck, United States
- Website
- www.pahc.com
PAHC Metrics
BasicAdvanced
$1.5B
15.42
$2.33
0.61
$0.48
1.34%
Price and volume
Market cap
$1.5B
Beta
0.61
52-week high
$60.08
52-week low
$28.25
Average daily volume
196K
Dividend rate
$0.48
Financial strength
Current ratio
3.172
Quick ratio
1.063
Long term debt to equity
209.058
Total debt to equity
217.971
Dividend payout ratio (TTM)
20.43%
Interest coverage (TTM)
4.15%
Profitability
EBITDA (TTM)
234.754
Gross margin (TTM)
32.57%
Net profit margin (TTM)
6.35%
Operating margin (TTM)
12.37%
Effective tax rate (TTM)
26.09%
Revenue per employee (TTM)
$610,000
Management effectiveness
Return on assets (TTM)
8.40%
Return on equity (TTM)
30.34%
Valuation
Price to earnings (TTM)
15.415
Price to revenue (TTM)
0.971
Price to book
4.03
Price to tangible book (TTM)
5.39
Price to free cash flow (TTM)
114.051
Free cash flow yield (TTM)
0.88%
Free cash flow per share (TTM)
0.315
Dividend yield (TTM)
1.34%
Forward dividend yield
1.34%
Growth
Revenue change (TTM)
25.98%
Earnings per share change (TTM)
198.65%
3-year revenue growth (CAGR)
15.32%
10-year revenue growth (CAGR)
7.22%
3-year earnings per share growth (CAGR)
49.27%
10-year earnings per share growth (CAGR)
1.80%
10-year dividend per share growth (CAGR)
1.84%
What the Analysts think about PAHC
Analyst ratings (Buy, Hold, Sell) for Phibro Animal Health stock.
PAHC Financial Performance
Revenues and expenses
PAHC Earnings Performance
Company profitability
PAHC News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.